SOCMA Members Beth Bosley of Boron Specialties and Robert Mott of Sun Chemical Serving as Panelists
Monday, June 12
12:00 - 1:30 PM (EDT)
Since enactment of the Frank R. Lautenberg Chemical Safety for the 21st Century Act last June, a logjam of new chemicals under review at the U.S. Environmental Protection Agency (EPA) unable to enter commerce has developed. EPA's Office of Pollution Prevention and Toxics (OPPT) is adjusting to new requirements in the 2016 amendments to the nation's primary chemicals law, the Toxic Substances Control Act (TSCA), and making progress in diminishing the backlog.
Former EPA officials have analyzed the types of decisions the agency is considering making for these new chemicals, the types of toxicity data being requested, and the marked change that this represents from past practices.
The panel will discuss those findings and the challenges facing small and large chemical manufacturers as well as their customers. They will offer suggestions for companies, trade associations, and EPA. The goal: to ensure new chemicals are responsibly reviewed, but to continue bringing innovative chemicals to market.
- EPA's prior practices for reviewing new chemicals
- What new requirements the 2016 TSCA amendments established
- EPA's interpretation of the amendments and what it means for the chemical review process
- What you can do to ensure a better chance at getting your chemical to market
- Beth D. Bosley
President, Boron Specialties LLC
- Robert Mott
Manager, Global Regulatory, Sun Chemical Corporation
- Jeffery Morris, Ph.D.
Director, OPPT, EPA
- Charles M. Auer
Senior Regulatory and Policy Advisor, Bergeson & Campbell P.C. (B&C®)
- Richard E. Engler, Ph.D.
Senior Chemist, B&C
- Lynn L. Bergeson
Managing Partner, B&C